|
1
|
Johnson VL and Hunter DJ: The epidemiology
of osteoarthritis. Best Pract Res Clin Rheumatol. 28:5–15. 2014.
View Article : Google Scholar
|
|
2
|
Gong Z, Liu R, Yu W, Wong TK, Guo Y and
Sun Y: Acutherapy for knee osteoarthritis relief in the elderly: A
systematic review and meta-analysis. Evid Based Complement Alternat
Med. 2019:18681072019. View Article : Google Scholar
|
|
3
|
Xia X, Wang X, Zheng Y, Jiang J and Hu J:
What role does pyroptosis play in microbial infection? J Cell
Physiol. 234:7885–7892. 2019. View Article : Google Scholar
|
|
4
|
Platnich JM and Muruve DA: NOD-like
receptors and inflammasomes: A review of their canonical and
non-canonical signaling pathways. Arch Biochem Biophys. 670:4–14.
2019. View Article : Google Scholar
|
|
5
|
Bergsbaken T, Fink SL and Cookson BT:
Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol.
7:99–109. 2009. View Article : Google Scholar
|
|
6
|
Schroder K, Muruve DA and Tschopp J:
Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome.
Curr Biol. 19:R262–R265. 2009. View Article : Google Scholar
|
|
7
|
Duprez L, Wirawan E, Vanden Berghe T and
Vandenabeele P: Major cell death pathways at a glance. Microbes
Infect. 11:1050–1062. 2009. View Article : Google Scholar
|
|
8
|
Dong W, Zhu Q, Yang B, Qin Q, Wang Y, Xia
X, Zhu X, Liu Z, Song E and Song Y: Polychlorinated biphenyl
quinone induces caspase 1-mediated pyroptosis through induction of
pro-inflammatory HMGB1-TLR4-NLRP3-GSDMD signal axis. Chem Res
Toxicol. 32:1051–1057. 2019. View Article : Google Scholar
|
|
9
|
Zhao LR, Xing RL, Wang PM, Zhang NS, Yin
SJ, Li XC and Zhang L: NLRP1 and NLRP3 inflammasomes mediate
LPS/ATP-induced pyroptosis in knee osteoarthritis. Mol Med Rep.
17:5463–5469. 2018.
|
|
10
|
Zhang L, Zhang L, Huang Z, Xing R, Li X,
Yin S, Mao J, Zhang N, Mei W, Ding L and Wang P: Increased HIF-1α
in knee osteoarthritis aggravate synovial fibrosis via
fibroblast-like synoviocyte pyroptosis. Oxid Med Cell Longev.
2019:63265172019.
|
|
11
|
Venereau E, De Leo F, Mezzapelle R,
Careccia G, Musco G and Bianchi ME: HMGB1 as biomarker and drug
target. Pharmacol Res. 111:534–544. 2016. View Article : Google Scholar
|
|
12
|
Burzynski LC and Clarke M: Death is coming
and the clot thickens, as pyroptosis feeds the fire. Immunity.
50:1339–1341. 2019. View Article : Google Scholar
|
|
13
|
Biscetti F, Flex A, Pecorini G, Angelini
F, Arena V, Stigliano E, Gremese E, Tolusso B and Ferraccioli G:
The role of high-mobility group box protein 1 in collagen
antibody-induced arthritis is dependent on vascular endothelial
growth factor. Clin Exp Immunol. 184:62–72. 2016. View Article : Google Scholar
|
|
14
|
Chung H, Hong SJ, Choi SW, Koo JY, Kim M,
Kim HJ, Park SB and Park CG: High mobility group box 1 secretion
blockade results in the reduction of early pancreatic islet graft
loss. Biochem Biophys Res Commun. 514:1081–1086. 2019. View Article : Google Scholar
|
|
15
|
Magna M and Pisetsky DS: The role of HMGB1
in the pathogenesis of inflammatory and autoimmune diseases. Mol
Med. 20:138–146. 2014. View Article : Google Scholar
|
|
16
|
Wang FC, Pei JX, Zhu J, Zhou NJ, Liu DS,
Xiong HF, Liu XQ, Lin DJ and Xie Y: Overexpression of HMGB1 A-box
reduced lipopolysaccharide-induced intestinal inflammation via
HMGB1/TLR4 signaling in vitro. World J Gastroenterol. 21:7764–7776.
2015. View Article : Google Scholar
|
|
17
|
Yu S, Zhang H, Hei Y, Yi X, Baskys A, Liu
W and Long Q: High mobility group box-1 (HMGB1) antagonist BoxA
suppresses status epilepticus-induced neuroinflammatory responses
associated with Toll-like receptor 2/4 down-regulation in rats.
Brain Res. 1717:44–51. 2019. View Article : Google Scholar
|
|
18
|
Tian X, Liu C, Shu Z and Chen G: Review:
Therapeutic targeting of HMGB1 in stroke. Curr Drug Deliv.
14:785–790. 2017. View Article : Google Scholar
|
|
19
|
Paudel YN, Angelopoulou E, Piperi C,
Balasubramaniam V, Othman I and Shaikh MF: Enlightening the role of
high mobility group box 1 (HMGB1) in inflammation: Updates on
receptor signalling. Eur J Pharmacol. 858:1724872019. View Article : Google Scholar
|
|
20
|
Vijayakumar EC, Bhatt LK and Prabhavalkar
KS: High mobility group box-1 (HMGB1): A potential target in
therapeutics. Curr Drug Targets. 20:1474–1485. 2019. View Article : Google Scholar
|
|
21
|
Lin SS, Yuan LJ, Niu CC, Tu YK, Yang CY
and Ueng SWN: Hyperbaric oxygen inhibits the HMGB1/RAGE signaling
pathway by upregulating Mir-107 expression in human osteoarthritic
chondrocytes. Osteoarthritis Cartilage. 27:1372–1381. 2019.
View Article : Google Scholar
|
|
22
|
Wagner G, Lehmann C, Bode C, Miosge N and
Schubert A: High mobility group box 1 protein in osteoarthritic
knee tissue and chondrogenic progenitor cells: An ex vivo and in
vitro study. Cartilage. Mar 26–2019.(Online ahead of print).
View Article : Google Scholar
|
|
23
|
Taniguchi N, Kawakami Y, Maruyama I and
Lotz M: HMGB proteins and arthritis. Hum Cell. 31:1–9. 2018.
View Article : Google Scholar
|
|
24
|
Alsousi AA and Igwe OJ: Redox-active trace
metal-induced release of high mobility group box 1(HMGB1) and
inflammatory cytokines in fibroblast-like synovial cells is
Toll-like receptor 4 (TLR4) dependent. Biochim Biophys Acta Mol
Basis Dis. 1864:3847–3858. 2018. View Article : Google Scholar
|
|
25
|
Nefla M, Holzinger D, Berenbaum F and
Jacques C: The danger from within: Alarmins in arthritis. Nat Rev
Rheumatol. 12:669–683. 2016. View Article : Google Scholar
|
|
26
|
Ke X, Jin G, Yang Y, Cao X, Fang R, Feng X
and Lei B: Synovial fluid HMGB-1 levels are associated with
osteoarthritis severity. Clin Lab. 61:809–818. 2015. View Article : Google Scholar
|
|
27
|
Kim HM and Kim YM: HMGB1: LPS delivery
vehicle for caspase-11-mediated pyroptosis. Immunity. 49:582–584.
2018. View Article : Google Scholar
|
|
28
|
Hou L, Yang Z, Wang Z, Zhang X, Zhao Y,
Yang H, Zheng B, Tian W, Wang S, He Z and Wang X:
NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1
secretion in acute lung injury induced by cardiopulmonary bypass.
Lab Invest. 98:1052–1064. 2018. View Article : Google Scholar
|
|
29
|
National Research Council (US) Institute
for Laboratory Animal Research, . Guide for the Care and Use of
Laboratory Animals. Washington (DC): National Academies Press (US);
1996, simplehttps://www.ncbi.nlm.nih.gov/books/NBK232589/doi:
10.17226/5140.
|
|
30
|
Xing R, Wang P, Zhao L, Xu B, Zhang N and
Li X: Mechanism of TRPA1 and TRPV4 participating in mechanical
hyperalgesia of rat experimental knee osteoarthritis. Arch
Rheumatol. 32:96–104. 2017. View Article : Google Scholar
|
|
31
|
Miao EA, Leaf IA, Treuting PM, Mao DP,
Dors M, Sarkar A, Warren SE, Wewers MD and Aderem A:
Caspase-1-induced pyroptosis is an innate immune effector mechanism
against intracellular bacteria. Nat Immunol. 11:1136–1142. 2010.
View Article : Google Scholar
|
|
32
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative CT method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar
|
|
33
|
Martel-Pelletier J, Raynauld JP, Mineau F,
Abram F, Paiement P, Delorme P and Pelletier JP: Levels of serum
biomarkers from a two-year multicentre trial are associated with
treatment response on knee osteoarthritis cartilage loss as
assessed by magnetic resonance imaging: An exploratory study.
Arthritis Res Ther. 19:1692017. View Article : Google Scholar
|
|
34
|
Samuelsson K, Magnussen RA, Alentorn-Geli
E, Krupic F, Spindler KP, Johansson C, Forssblad M and Karlsson J:
Equivalent knee injury and osteoarthritis outcome scores 12 and 24
months after anterior cruciate ligament reconstruction: Results
from the swedish national knee ligament register. Am J Sports Med.
45:2085–2091. 2017. View Article : Google Scholar
|
|
35
|
Steinhaus ME, Christ AB and Cross MB:
Total knee arthroplasty for knee osteoarthritis: Support for a
foregone conclusion? HSS J. 13:207–210. 2017. View Article : Google Scholar
|
|
36
|
Kong R, Gao J, Si Y and Zhao D:
Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p
expressions correlates with risk and disease severity of knee
osteoarthritis. Am J Transl Res. 9:2852–2864. 2017.
|
|
37
|
Zhang L, Xing R, Huang Z, Zhang N, Zhang
L, Li X and Wang P: Inhibition of synovial macrophage pyroptosis
alleviates synovitis and fibrosis in knee osteoarthritis. Mediators
Inflamm. 2019:21659182019. View Article : Google Scholar
|
|
38
|
Zhang C, Yu W, Huang C, Ding Q, Liang C,
Wang L, Hou Z and Zhang Z: Chrysin protects human osteoarthritis
chondrocytes by inhibiting inflammatory mediator expression via
HMGB1 suppression. Mol Med Rep. 19:1222–1229. 2019.
|
|
39
|
Shu Z, Miao X, Tang T, Zhan P, Zeng L and
Jiang Y: The GSK-3β/β-catenin signaling pathway is involved in
HMGB1-induced chondrocyte apoptosis and cartilage matrix
degradation. Int J Mol Med. 45:769–778. 2020.
|
|
40
|
Wähämaa H, Schierbeck H, Hreggvidsdottir
HS, Palmblad K, Aveberger AC, Andersson U and Harris HE: High
mobility group box protein 1 in complex with lipopolysaccharide or
IL-1 promotes an increased inflammatory phenotype in synovial
fibroblasts. Arthritis Res Ther. 13:R1362011. View Article : Google Scholar
|
|
41
|
Garcia-Arnandis I, Guillen MI, Gomar F,
Pelletier JP, Martel-Pelletier J and Alcaraz MJ: High mobility
group box 1 potentiates the pro-inflammatory effects of
interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther.
12:R1652010. View
Article : Google Scholar
|
|
42
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: A disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar
|
|
43
|
Terada C, Yoshida A, Nasu Y, Mori S,
Tomono Y, Tanaka M, Takahashi HK, Nishibori M, Ozaki T and Nishida
K: Gene expression and localization of high-mobility group box
chromosomal protein-1 (HMGB-1)in human osteoarthritic cartilage.
Acta Med Okayama. 65:369–377. 2011.
|
|
44
|
Fan C, Zhao X, Guo X, Cao X and Cai J:
P2X4 promotes interleukin-1β production in osteoarthritis via
NLRP1. Mol Med Rep. 9:340–344. 2014. View Article : Google Scholar
|
|
45
|
Harapas CR, Steiner A, Davidson S and
Masters SL: An update on autoinflammatory diseases:
Inflammasomopathies. Curr Rheumatol Rep. 20:402018. View Article : Google Scholar
|
|
46
|
Kesavardhana S and Kanneganti TD:
Mechanisms governing inflammasome activation, assembly and
pyroptosis induction. Int Immunol. 29:201–210. 2017. View Article : Google Scholar
|
|
47
|
Zhang B, Zhang Y, Xu T, Yin Y, Huang R,
Wang Y, Zhang J, Huang D and Li W: Chronic dexamethasone treatment
results in hippocampal neurons injury due to activate NLRP1
inflammasome in vitro. Int Immunopharmacol. 49:222–230. 2017.
View Article : Google Scholar
|
|
48
|
Kim EJ, Park SY, Baek SE, Jang MA, Lee WS,
Bae SS, Kim K and Kim CD: HMGB1 Increases IL-1β production in
vascular smooth muscle cells via NLRP3 inflammasome. Front Physiol.
9:3132018. View Article : Google Scholar
|
|
49
|
Geng Y, Ma Q, Liu YN, Peng N, Yuan FF, Li
XG, Li M, Wu YS, Li BL, Song WB, et al: Heatstroke induces liver
injury via IL-1β and HMGB1-induced pyroptosis. J Hepatol.
63:622–633. 2015. View Article : Google Scholar
|
